(19)
(11) EP 4 373 496 A1

(12)

(43) Date of publication:
29.05.2024 Bulletin 2024/22

(21) Application number: 22713729.6

(22) Date of filing: 02.03.2022
(51) International Patent Classification (IPC): 
A61K 31/575(2006.01)
A61K 31/4375(2006.01)
A61K 31/58(2006.01)
A61K 45/06(2006.01)
A61P 17/08(2006.01)
A61P 17/14(2006.01)
A61K 9/08(2006.01)
 A61K 31/122(2006.01)
A61K 31/57(2006.01)
A61K 31/05(2006.01)
A61P 17/00(2006.01)
A61P 17/10(2006.01)
A61K 9/06(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/575; A61K 31/122; A61K 31/58; A61K 31/57; A61K 31/4375; A61K 31/05; A61K 45/06; A61P 17/10; A61P 17/14; A61P 17/08; A61P 17/00; A61K 9/08; A61K 9/0014
 
C-Sets:
  1. A61K 31/4375, A61K 2300/00;
  2. A61K 31/05, A61K 2300/00;
  3. A61K 31/575, A61K 2300/00;
  4. A61K 31/122, A61K 2300/00;
  5. A61K 31/58, A61K 2300/00;
  6. A61K 31/57, A61K 2300/00;
(86) International application number:
PCT/IB2022/051834
(87) International publication number:
WO 2022/185228 (09.09.2022 Gazette 2022/36)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 02.03.2021 IT 202100004898

(71) Applicants:
  • S&R Farmaceutici S.p.A.
    06083 Bastia Umbra (IT)
  • G&C Biotech S.r.l.
    06083 Bastia Umbra (PG) (IT)

(72) Inventors:
  • CLERICI, Carlo
    06034 Foligno (PG) (IT)
  • CLERICI, Graziano
    06035 Gualdo Cattaneo (PG) (IT)
  • CRUCIANI, Gabriele
    06135 Perugia (IT)
  • FIORETTI, Bernard
    06034 Foligno (PG) (IT)
  • LEONARDI, Lucio
    06035 Gualdo Cattaneo (PG) (IT)

(74) Representative: Grasso, Vincenzo 
c/o Studio Legale Grasso Stradi di Olgia Vecchia s.n.c. Centro Direzionale Milano Due Palazzo Canova 1
20054 Segrate (MI)
20054 Segrate (MI) (IT)

   


(54) COMPOSITION OR FORMULATION COMPRISING ONE OR MORE 5-ALPHA-REDUCTASE INHIBITORS AND ONE OR MORE BILE ACIDS